•
HR
HRTX
Heron Therapeutics, Inc.
yahooPHARMACEUTICAL PREPARATIONS
--
Price Chart
Market Cap
267.71M
Volume
1.31M
52W High
$2.68
52W Low
$1.00
Open
$0.00
Prev Close
$1.42
Day Range
0.00 - 0.00
About Heron Therapeutics, Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
Latest News
Heron Therapeutics Announces Appointment of Thomas Cusack to Board of Directors
GlobeNewswire Inc.•Oct 29
Heron Therapeutics to Report Third Quarter 2024 Financial Results On Tuesday, November 12, 2024
Benzinga•Oct 29
Chemotherapy Induced Nausea and Vomiting Treatment Market is Set to Reach US$ 12,688.0 Million by 2034 | Fact.MR
GlobeNewswire Inc.•Sep 17
Merck (MRK) Gets Exclusive Rights to Opevesostat From Partner
Zacks Investment Research•Jul 2
FDA Rejects Rocket's (RCKT) Gene Therapy BLA for Rare Disease
Zacks Investment Research•Jul 1
FDA Expands AbbVie's (ABBV) Epkinly Label in Follicular Lymphoma
Zacks Investment Research•Jun 27
AstraZeneca's (AZN) Imfinzi Meets Study Goal in Bladder Cancer
Zacks Investment Research•Jun 26
Ionis Pharmaceuticals (IONS) Soars 6.8%: Is Further Upside Left in the Stock?
Zacks Investment Research•Jun 25